These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4828165)

  • 21. [Pharmacokinetic properties of the delayed-action form of lithium carbonate].
    Kabes J; Kabesová L
    Cesk Psychiatr; 1983 Apr; 79(2):102-6. PubMed ID: 6407766
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison between 2 preparations forms: slide-effects of prophylactic lithium therapy].
    Laurell B; Persson G
    Lakartidningen; 1970 Jul; 67(27):3083-5. PubMed ID: 4918342
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of dosage schedules for delayed-action lithium carbonate].
    Balon R; Kabesh Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of lithium adverse effects between a short-term (Quilonum) and a depot preparation (Lithium Duriles)].
    Matussek N; von Hessling P
    Nervenarzt; 1971 Jul; 42(7):376-8. PubMed ID: 5561070
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
    Castrogiovanni P
    Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium absorption from sustained-release tablets (Duretter).
    Amdisen A; Sjögren J
    Acta Pharm Suec; 1968 Nov; 5(5):465-72. PubMed ID: 5732567
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prophylactic treatment of manic-depressive psychoses with lithium carbonate. Theoretical and practical value of the study of variations of plasma concentrations].
    Hakim C; Pichot P
    Ann Med Psychol (Paris); 1972 Feb; 1(2):238-46. PubMed ID: 5051251
    [No Abstract]   [Full Text] [Related]  

  • 30. Lithium carbonate (a review).
    Noyes R
    Dis Nerv Syst; 1969 May; 30(5):318-21. PubMed ID: 4891795
    [No Abstract]   [Full Text] [Related]  

  • 31. The long-term efficacy and tolerability of carbolithium once a day: an interim analysis at 6 months.
    Durbano F; Mencacci C; Dorigo D; Riva M; Buffa G
    Clin Ter; 2002; 153(3):161-6. PubMed ID: 12161976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium carbonate treatment in psychiatry.
    Sikes JC; Sikes SC
    Dis Nerv Syst; 1970 Jan; 31(1):52-5. PubMed ID: 5458977
    [No Abstract]   [Full Text] [Related]  

  • 33. Lithium carbonate in the treatment and prophylaxis of recurrent affective disorders: long term follow-up.
    Warick LH
    Bull Los Angeles Neurol Soc; 1970 Oct; 35(4):169-80. PubMed ID: 4990519
    [No Abstract]   [Full Text] [Related]  

  • 34. Lithium carbonate absorption in humans.
    Sugita ET; Stokes JW; Frazer A; Grof P; Mendels J; Goldstein FJ; Niebergall PJ
    J Clin Pharmacol; 1973 Jul; 13(7):264-70. PubMed ID: 4488996
    [No Abstract]   [Full Text] [Related]  

  • 35. [2 cases of severe poisoning by lithium carbonate].
    Favarel-Garrigues B; Favarel-Garrigues JC; Bourgeois M
    Ann Med Psychol (Paris); 1972 Feb; 1(2):253-7. PubMed ID: 5051253
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experience with the preparation lithium carbonicum retard in psychiatry (author's transl)].
    Zapletálek M; Hanus H; Kindernayová H; Kucerová H
    Cesk Psychiatr; 1981 Apr; 77(2):110-5. PubMed ID: 6790179
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experience in the treatment of manic-depressive states with orally administered enteric-coated lithium carbonate tablets].
    Ishida M; Orihashi Y; Igarashi A; Kakita Y; Takeuchi A
    Iryo; 1972 Mar; 26(3):229-37. PubMed ID: 5027291
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of antacid on the bioavailabiity of lithium carbonate.
    Goode DL; Newton DW; Ueda CT; Wilson JE; Wulf BG; Kafonek D
    Clin Pharm; 1984; 3(3):284-7. PubMed ID: 6428800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacy for physicians. Oral slow-release preparations--a review].
    Sjögren J
    Lakartidningen; 1972 Jun; 69():Suppl 2:33-40. PubMed ID: 4566732
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of the "on-off" phenomenon in Parkinsonism with lithium carbonate.
    Coffey CE; Ross DR; Ferren EL; Sullivan JL; Olanow CW
    Ann Neurol; 1982 Oct; 12(4):375-9. PubMed ID: 6816132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.